Selected research
Industry Growth & Trends
Global Pharmaceutical Grade Niacinamide Industry Growth and Trends Forecast to 2032
Market perspective
The global Pharmaceutical Grade Niacinamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Grade Niacinamide include Zhejiang Lanbo Biotechnology, Lonza, Vertellus, Vanetta, Lasons India, Jubilant Life Sciences, DSM and Brother Enterprises, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmaceutical Grade Niacinamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Grade Niacinamide market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Grade Niacinamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Grade Niacinamide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pharmaceutical Grade Niacinamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Grade Niacinamide Market by Company
Zhejiang Lanbo Biotechnology
Lonza
Vertellus
Vanetta
Lasons India
Jubilant Life Sciences
DSM
Brother Enterprises
Pharmaceutical Grade Niacinamide Segment by Type
Liquid
Crystal
Powder
Pharmaceutical Grade Niacinamide Segment by Application
Pharmaceutical Industry
Daily Chemicals
Others
Pharmaceutical Grade Niacinamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Niacinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Niacinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Niacinamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade Niacinamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pharmaceutical Grade Niacinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Crystal
- Powder
Applications
- Pharmaceutical Industry
- Daily Chemicals
- Others
Companies covered
- Zhejiang Lanbo Biotechnology
- Lonza
- Vertellus
- Vanetta
- Lasons India
- Jubilant Life Sciences
- DSM
- Brother Enterprises
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharmaceutical Grade Niacinamide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharmaceutical Grade Niacinamide Sales Estimates and Forecasts (2021-2032)
- 1.3 Pharmaceutical Grade Niacinamide Market by Type
- 1.3.1 Liquid
- 1.3.2 Crystal
- 1.3.3 Powder
- 1.4 Global Pharmaceutical Grade Niacinamide Market Size by Type
- 1.4.1 Global Pharmaceutical Grade Niacinamide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pharmaceutical Grade Niacinamide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pharmaceutical Grade Niacinamide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pharmaceutical Grade Niacinamide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pharmaceutical Grade Niacinamide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pharmaceutical Grade Niacinamide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pharmaceutical Grade Niacinamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pharmaceutical Grade Niacinamide Industry Trends
- 2.2 Pharmaceutical Grade Niacinamide Industry Drivers
- 2.3 Pharmaceutical Grade Niacinamide Industry Opportunities and Challenges
- 2.4 Pharmaceutical Grade Niacinamide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pharmaceutical Grade Niacinamide Revenue (2021-2026)
- 3.2 Global Top Players by Pharmaceutical Grade Niacinamide Sales (2021-2026)
- 3.3 Global Top Players by Pharmaceutical Grade Niacinamide Price (2021-2026)
- 3.4 Global Pharmaceutical Grade Niacinamide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Niacinamide Major Company Production Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Niacinamide Company, Product Type & Application
- 3.7 Global Pharmaceutical Grade Niacinamide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Grade Niacinamide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Grade Niacinamide Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Grade Niacinamide Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade Niacinamide Regional Status and Outlook
- 4.1 Global Pharmaceutical Grade Niacinamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pharmaceutical Grade Niacinamide Historic Market Size by Region
- 4.2.1 Global Pharmaceutical Grade Niacinamide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pharmaceutical Grade Niacinamide Sales in Value by Region (2021-2026)
- 4.2.3 Global Pharmaceutical Grade Niacinamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pharmaceutical Grade Niacinamide Forecasted Market Size by Region
- 4.3.1 Global Pharmaceutical Grade Niacinamide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pharmaceutical Grade Niacinamide Sales in Value by Region (2027-2032)
- 4.3.3 Global Pharmaceutical Grade Niacinamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharmaceutical Grade Niacinamide by Application
- 5.1 Pharmaceutical Grade Niacinamide Market by Application
- 5.1.1 Pharmaceutical Industry
- 5.1.2 Daily Chemicals
- 5.1.3 Others
- 5.2 Global Pharmaceutical Grade Niacinamide Market Size by Application
- 5.2.1 Global Pharmaceutical Grade Niacinamide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pharmaceutical Grade Niacinamide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pharmaceutical Grade Niacinamide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pharmaceutical Grade Niacinamide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pharmaceutical Grade Niacinamide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pharmaceutical Grade Niacinamide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pharmaceutical Grade Niacinamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhejiang Lanbo Biotechnology
- 6.1.1 Zhejiang Lanbo Biotechnology Company Information
- 6.1.2 Zhejiang Lanbo Biotechnology Business Overview
- 6.1.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Product Portfolio
- 6.1.5 Zhejiang Lanbo Biotechnology Recent Developments
- 6.2 Lonza
- 6.2.1 Lonza Company Information
- 6.2.2 Lonza Business Overview
- 6.2.3 Lonza Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Lonza Pharmaceutical Grade Niacinamide Product Portfolio
- 6.2.5 Lonza Recent Developments
- 6.3 Vertellus
- 6.3.1 Vertellus Company Information
- 6.3.2 Vertellus Business Overview
- 6.3.3 Vertellus Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Vertellus Pharmaceutical Grade Niacinamide Product Portfolio
- 6.3.5 Vertellus Recent Developments
- 6.4 Vanetta
- 6.4.1 Vanetta Company Information
- 6.4.2 Vanetta Business Overview
- 6.4.3 Vanetta Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Vanetta Pharmaceutical Grade Niacinamide Product Portfolio
- 6.4.5 Vanetta Recent Developments
- 6.5 Lasons India
- 6.5.1 Lasons India Company Information
- 6.5.2 Lasons India Business Overview
- 6.5.3 Lasons India Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Lasons India Pharmaceutical Grade Niacinamide Product Portfolio
- 6.5.5 Lasons India Recent Developments
- 6.6 Jubilant Life Sciences
- 6.6.1 Jubilant Life Sciences Company Information
- 6.6.2 Jubilant Life Sciences Business Overview
- 6.6.3 Jubilant Life Sciences Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Jubilant Life Sciences Pharmaceutical Grade Niacinamide Product Portfolio
- 6.6.5 Jubilant Life Sciences Recent Developments
- 6.7 DSM
- 6.7.1 DSM Company Information
- 6.7.2 DSM Business Overview
- 6.7.3 DSM Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 DSM Pharmaceutical Grade Niacinamide Product Portfolio
- 6.7.5 DSM Recent Developments
- 6.8 Brother Enterprises
- 6.8.1 Brother Enterprises Company Information
- 6.8.2 Brother Enterprises Business Overview
- 6.8.3 Brother Enterprises Pharmaceutical Grade Niacinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Brother Enterprises Pharmaceutical Grade Niacinamide Product Portfolio
- 6.8.5 Brother Enterprises Recent Developments
7 North America by Country
- 7.1 North America Pharmaceutical Grade Niacinamide Sales by Country
- 7.1.1 North America Pharmaceutical Grade Niacinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
- 7.1.3 North America Pharmaceutical Grade Niacinamide Sales Forecast by Country (2027-2032)
- 7.2 North America Pharmaceutical Grade Niacinamide Market Size by Country
- 7.2.1 North America Pharmaceutical Grade Niacinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pharmaceutical Grade Niacinamide Market Size by Country (2021-2026)
- 7.2.3 North America Pharmaceutical Grade Niacinamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pharmaceutical Grade Niacinamide Sales by Country
- 8.1.1 Europe Pharmaceutical Grade Niacinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
- 8.1.3 Europe Pharmaceutical Grade Niacinamide Sales Forecast by Country (2027-2032)
- 8.2 Europe Pharmaceutical Grade Niacinamide Market Size by Country
- 8.2.1 Europe Pharmaceutical Grade Niacinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pharmaceutical Grade Niacinamide Market Size by Country (2021-2026)
- 8.2.3 Europe Pharmaceutical Grade Niacinamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pharmaceutical Grade Niacinamide Sales by Country
- 9.1.1 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pharmaceutical Grade Niacinamide Market Size by Country
- 9.2.1 Asia-Pacific Pharmaceutical Grade Niacinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pharmaceutical Grade Niacinamide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pharmaceutical Grade Niacinamide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pharmaceutical Grade Niacinamide Sales by Country
- 10.1.1 South America Pharmaceutical Grade Niacinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
- 10.1.3 South America Pharmaceutical Grade Niacinamide Sales Forecast by Country (2027-2032)
- 10.2 South America Pharmaceutical Grade Niacinamide Market Size by Country
- 10.2.1 South America Pharmaceutical Grade Niacinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pharmaceutical Grade Niacinamide Market Size by Country (2021-2026)
- 10.2.3 South America Pharmaceutical Grade Niacinamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pharmaceutical Grade Niacinamide Sales by Country
- 11.1.1 Middle East and Africa Pharmaceutical Grade Niacinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pharmaceutical Grade Niacinamide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pharmaceutical Grade Niacinamide Market Size by Country
- 11.2.1 Middle East and Africa Pharmaceutical Grade Niacinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pharmaceutical Grade Niacinamide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pharmaceutical Grade Niacinamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pharmaceutical Grade Niacinamide Value Chain Analysis
- 12.1.1 Pharmaceutical Grade Niacinamide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pharmaceutical Grade Niacinamide Production Mode & Process
- 12.2 Pharmaceutical Grade Niacinamide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pharmaceutical Grade Niacinamide Distributors
- 12.2.3 Pharmaceutical Grade Niacinamide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst